[1]Yu L,Tian YJ.Clinical study on the pathogenesis of endometriosis[J].J Shandong University (Medical Science Edition),2013,51(2):79-83.[于玲,田永杰.子宫内膜异位症发病相关因素的临床研究[J].山东大学学报(医学版),2013,51(2):79-83.]
[2]Li YN,Wang DB,Chen YH,et al.Analysis of clinical features and clinical significance of different types of endometriosis[J].J Practical Obstetrics and Gynecology,2015,31(1):34-36.[李雅男,王丹波,陈英汉,等.不同类型子宫内膜异位症临床特点及意义分析[J].实用妇产科杂志,2015,31(1):34-36.]
[3]Wu YK,Liao GD,Zhang Z,et al.In malignant transformation of endometriosis and ovarian cancer and correlation between prognosis analysis[J].J Practical Obstetrics and Gynecology,2014,30(9):703-707.[吴雨珂,廖光东,张竹,等.卵巢子宫内膜异位症恶变与卵巢癌的相关性研究及预后分析[J].实用妇产科杂志,2014,30(9):703-707.]
[4]Song Z.Clinical analysis of endometriosis and ovarian cancer[J].Tianjin Medicine,2010,38(10):916-917.[宋志.单纯子宫内膜异位症与合并卵巢癌的临床分析[J].天津医药,2010,38(10):916-917.]
[5]Song JP.Clinical analysis of the relationship between endometriosis and ovarian cancer[J].Modern Oncology,2015,23 (10):1432-1434.[宋建平.子宫内膜异位症与卵巢癌相关性临床分析[J].现代肿瘤医学,2015,23(10):1432-1434.]
[6]Ma ZH,Lv DH.Progress in clinical diagnosis and treatment of ovarian cancer associated with endometriosis[J].Chinese J Maternal and Child Clinical Medicine (Electronic Version),2013,9(6):828-832.[马志华,吕东昊.子宫内膜异位症相关卵巢癌的临床诊治进展[J].中华妇幼临床医学杂志(电子版),2013,9(6):828-832.]
[7]Su XH,Song DR,Zhang W,et al.Study on invasion and metastasis of endometrial stromal cells in endometriosis[J].Tianjin Medicine,2014,45(12):1163-1167,1250.[苏晓华,宋殿荣,张崴,等.子宫内膜异位症中子宫内膜间质细胞侵袭、转移能力的研究[J].天津医药,2014,45(12):1163-1167,1250.]
[8]Sun PR.New progress in modern obstetrics and gynecology[J].Progress in Malignant Transformation of Endometriosis Research,2012,21(4):316-318.[孙蓬然.卵巢子宫内膜异位症恶变研究的新进展[J].现代妇产科进展,2012,21(4):316-318.]
[9]Pei HL,Yu H.Ovarian endometriosis canceration clinical analysis[J].China Medical Innovation,2012,09(19):116-117.[裴慧琳,于欢.卵巢子宫内膜异位恶变的临床分析[J].中国医学创新,2012,09(19):116-117.]
[10]Zhang JW,Jiang JG,Zhai ZY,et al.The expression of apoptosis related gene PDCD5 in non-small cell lung cancer and its clinical significance[J].China J Gerontology,2013,33(9):2006-2008.[张婧雯,蒋军广,翟展艺,等.凋亡相关基因PDCD5在非小细胞肺癌中的表达及临床意义[J].中国老年学杂志,2013,33(9):2006-2008.]
[11]Jiang Y,Yang DQ,Wang CY,et al.Research progress on relationship between tumor-suppressing gene PDCD4 and tumor[J].Modern Oncology,2015,23(22):3363-3366.[姜艳,杨大群,王聪洋,等.抑癌基因PDCD4与肿瘤关系的研究进展[J].现代肿瘤医学,2015,23(22):3363-3366.]
[12]Mei TH,Dai LL,Zhang MC,et al.PDCD5 gene on the efficacy of cisplatin in nude mice with A549 lung cancer[J].J China Medical University,2015,44(11):1002-1006.[梅同华,戴玲丽,张明川,等.PDCD5基因对顺铂在裸鼠A549肺癌中疗效的协同作用[J].中国医科大学学报,2015,44(11):1002-1006.]
[13]Nassif J,Abbasi SA,Nassar A,et al.The role of NADPH-derived reactive oxygen species production in the pathogenesis ofendometriosis:a novel mechanistic approach[J].J Biol Regul Homeost Agents,2016,30(1):31-40.
[14]Hatirnaz S,Colak S,Reis A.Cystic endometriosis in a huge degenerated subserous leiomyoma mimicking bilateral multicystic endometriomas in an infertile woman with diminished ovarian reserve:a rare endometriotic implantation[J].Case Rep Obstet Gynecol,2016,32:3943-3946.
[15]Ma X,Hui Y,Lin L.Possible relevance of tumor-related genes mutation to malignant transformation of endometriosis[J].Eur J Gynaecol Oncol,2016,37(1):89-94.
[16]Yu SS,Qian Y.Clinical analysis of endometriosis associated ovarian cancer[J].Chinese J Continuing Medical Education,2015,11(29):102-103.[余莎莎,钱英.子宫内膜异位症相关卵巢癌的临床分析[J].中国继续医学教育,2015,11(29):102-103.]